The U.S. Securities and Exchange Commission submitted two new regulatory reviews to the White House on March 20, involving digital asset and hedge fund disclosure requirements. These include registration exemptions for digital asset companies and adjustments to Form PF reporting.

Biopharmaceutical company Acurx Pharmaceuticals approved a $10 million bitcoin purchase plan to hedge against R&D funding depreciation risks; Enfusion plans to invest 10% of excess cash in bitcoin and ethereum; Nature's Miracle launched a $5 million bitcoin reserve plan, demonstrating that cryptocurrencies are being incorporated into reserve assets. Meanwhile, demand for crypto custody services has grown 40%.

As artificial intelligence impacts software revenue, private credit markets face pressure with default rates climbing to 5.8%. Analysts warn that currency expansion may be necessary, with Bitcoin emerging as a hedge tool for investors, its appeal rising amid uncertainty. Markets need to monitor private credit dynamics and the impact of policy adjustments on Bitcoin's price.

BlackRock's head of digital assets stated that BlackRock's Bitcoin ETF has negative returns despite recording $26 billion in inflows, ranking fourth globally. This reflects that Bitcoin is experiencing intense turnover and accumulation. Most investors are choosing to buy on dips, with only a small number of hedge funds engaging in short-term trading.

Gate News 機器人消息，hedge 已上線Alpha